Global Influenza Vaccine Market Overview And Scope:
Global Influenza Vaccine Market Size was estimated at USD 5357.7 million in 2022 and is projected to reach USD 6716.08 million by 2028, exhibiting a CAGR of 3.84% during the forecast period.
The Global Influenza Vaccine Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Influenza Vaccine utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO
Global Influenza Vaccine Market Segmentation
By Type, Influenza Vaccine market has been segmented into:Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
By Application, Influenza Vaccine market has been segmented into:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Influenza Vaccine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Influenza Vaccine market.
Top Key Players Covered in Influenza Vaccine market are:
CSL
GSK
Sanofi Pasteur
Mylan
Hulan Bio
AstraZeneca
CCBIO
Objective to buy this Report:
1. Influenza Vaccine analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Influenza Vaccine market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Influenza Vaccine Market by Type
5.1 Influenza Vaccine Market Overview Snapshot and Growth Engine
5.2 Influenza Vaccine Market Overview
5.3 Trivalent Influenza Vaccine
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Trivalent Influenza Vaccine: Geographic Segmentation
5.4 Quadrivalent Influenza Vaccine
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Quadrivalent Influenza Vaccine: Geographic Segmentation
Chapter 6: Influenza Vaccine Market by Application
6.1 Influenza Vaccine Market Overview Snapshot and Growth Engine
6.2 Influenza Vaccine Market Overview
6.3 For Children (6 months to 3 years)
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 For Children (6 months to 3 years): Geographic Segmentation
6.4 For Adults and Children over 3 years
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 For Adults and Children over 3 years: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Influenza Vaccine Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Influenza Vaccine Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Influenza Vaccine Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 CSL
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 GSK
7.4 SANOFI PASTEUR
7.5 MYLAN
7.6 HULAN BIO
7.7 ASTRAZENECA
7.8 CCBIO
Chapter 8: Global Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Trivalent Influenza Vaccine
8.2.2 Quadrivalent Influenza Vaccine
8.3 Historic and Forecasted Market Size By Application
8.3.1 For Children (6 months to 3 years)
8.3.2 For Adults and Children over 3 years
Chapter 9: North America Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Trivalent Influenza Vaccine
9.4.2 Quadrivalent Influenza Vaccine
9.5 Historic and Forecasted Market Size By Application
9.5.1 For Children (6 months to 3 years)
9.5.2 For Adults and Children over 3 years
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Trivalent Influenza Vaccine
10.4.2 Quadrivalent Influenza Vaccine
10.5 Historic and Forecasted Market Size By Application
10.5.1 For Children (6 months to 3 years)
10.5.2 For Adults and Children over 3 years
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Trivalent Influenza Vaccine
11.4.2 Quadrivalent Influenza Vaccine
11.5 Historic and Forecasted Market Size By Application
11.5.1 For Children (6 months to 3 years)
11.5.2 For Adults and Children over 3 years
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Trivalent Influenza Vaccine
12.4.2 Quadrivalent Influenza Vaccine
12.5 Historic and Forecasted Market Size By Application
12.5.1 For Children (6 months to 3 years)
12.5.2 For Adults and Children over 3 years
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Trivalent Influenza Vaccine
13.4.2 Quadrivalent Influenza Vaccine
13.5 Historic and Forecasted Market Size By Application
13.5.1 For Children (6 months to 3 years)
13.5.2 For Adults and Children over 3 years
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Influenza Vaccine Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Trivalent Influenza Vaccine
14.4.2 Quadrivalent Influenza Vaccine
14.5 Historic and Forecasted Market Size By Application
14.5.1 For Children (6 months to 3 years)
14.5.2 For Adults and Children over 3 years
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Influenza Vaccine Scope:
|
Report Data
|
Influenza Vaccine Market
|
|
Influenza Vaccine Market Size in 2025
|
USD XX million
|
|
Influenza Vaccine CAGR 2025 - 2032
|
XX%
|
|
Influenza Vaccine Base Year
|
2024
|
|
Influenza Vaccine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO.
|
|
Key Segments
|
By Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
By Applications
For Children (6 months to 3 years)
For Adults and Children over 3 years
|
